Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

The rotavirus experience in Mexico: discovery to control.

Patel MM, Parashar UD, Santosham M, Richardson V.

Clin Infect Dis. 2013 Feb;56(4):548-51. doi: 10.1093/cid/cis939. Epub 2012 Dec 27.

PMID:
23271788
[PubMed - indexed for MEDLINE]
Free Article
2.

Rotavirus vaccines: targeting the developing world.

Glass RI, Bresee JS, Turcios R, Fischer TK, Parashar UD, Steele AD.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S160-6.

PMID:
16088799
[PubMed - indexed for MEDLINE]
Free Article
3.

Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality.

Tate JE, Patel MM, Cortese MM, Lopman BA, Gentsch JR, Fleming J, Steele AD, Parashar UD.

Expert Rev Vaccines. 2012 Feb;11(2):211-20. doi: 10.1586/erv.11.184. Review.

PMID:
22309669
[PubMed - indexed for MEDLINE]
4.

Rotavirus vaccine: early introduction in Latin America-risks and benefits.

Pérez-Vargas J, Isa P, López S, Arias CF.

Arch Med Res. 2006 Jan;37(1):1-10. Review.

PMID:
16314179
[PubMed - indexed for MEDLINE]
5.

Rotarix®: vaccine performance 6 years postlicensure.

O'Ryan M, Lucero Y, Linhares AC.

Expert Rev Vaccines. 2011 Dec;10(12):1645-59. doi: 10.1586/erv.11.152. Review.

PMID:
22085167
[PubMed - indexed for MEDLINE]
6.

Efficacy of the human rotavirus vaccine RIX4414 in malnourished children.

Perez-Schael I, Salinas B, Tomat M, Linhares AC, Guerrero ML, Ruiz-Palacios GM, Bouckenooghe A, Yarzabal JP.

J Infect Dis. 2007 Aug 15;196(4):537-40. Epub 2007 Jun 29.

PMID:
17624838
[PubMed - indexed for MEDLINE]
Free Article
7.

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, Dove W, Montenegro FM, Correia JB, Nakagomi O, Cunliffe NA, Hart CA.

Arch Virol. 2008;153(3):591-3. doi: 10.1007/s00705-007-0028-z. Epub 2008 Jan 4.

PMID:
18175037
[PubMed - indexed for MEDLINE]
8.

Rotavirus disease burden, Nicaragua 2001-2005: defining the potential impact of a rotavirus vaccination program.

Amador JJ, Vasquez J, Orozco M, Pedreira C, Malespin O, De Oliveira LH, Tate J, Parashar U, Patel M.

Int J Infect Dis. 2010 Jul;14(7):e592-5. doi: 10.1016/j.ijid.2009.08.014. Epub 2009 Dec 22.

PMID:
20022778
[PubMed - indexed for MEDLINE]
Free Article
9.

Live attenuated human rotavirus vaccine, Rotarix.

Bernstein DI.

Semin Pediatr Infect Dis. 2006 Oct;17(4):188-94. Review.

PMID:
17055369
[PubMed - indexed for MEDLINE]
10.

Rotavirus vaccines: an overview.

Dennehy PH.

Clin Microbiol Rev. 2008 Jan;21(1):198-208. doi: 10.1128/CMR.00029-07. Review.

PMID:
18202442
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Effects of vaccine on rotavirus disease in the pediatric population.

Dennehy PH.

Curr Opin Pediatr. 2012 Feb;24(1):76-84. doi: 10.1097/MOP.0b013e32834ee594. Review.

PMID:
22189398
[PubMed - indexed for MEDLINE]
12.

Impact of rotavirus vaccination on diarrhea-related hospitalizations among children < 5 years of age in Mexico.

Quintanar-Solares M, Yen C, Richardson V, Esparza-Aguilar M, Parashar UD, Patel MM.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S11-5. doi: 10.1097/INF.0b013e3181fefb32.

PMID:
21183834
[PubMed - indexed for MEDLINE]
13.

Rotavirus infection: an update on management and prevention.

Dennehy PH.

Adv Pediatr. 2012;59(1):47-74. doi: 10.1016/j.yapd.2012.04.002. Review.

PMID:
22789574
[PubMed - indexed for MEDLINE]
14.

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.

Vaccine. 2012 Feb 14;30(8):1521-8. doi: 10.1016/j.vaccine.2011.11.052. Epub 2011 Nov 23.

PMID:
22119590
[PubMed - indexed for MEDLINE]
15.

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R.

BMC Infect Dis. 2008 Jul 29;8:103. doi: 10.1186/1471-2334-8-103.

PMID:
18664280
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Cost-effectiveness analysis of a rotavirus immunization program for the United States.

Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI.

JAMA. 1998 May 6;279(17):1371-6.

PMID:
9582045
[PubMed - indexed for MEDLINE]
17.

Outstanding challenges for rotavirus vaccine introduction in low-income countries--a systematic review.

Ustrup M, Madsen LB, Bygbjerg IC, Konradsen F.

Dan Med Bull. 2011 Oct;58(10):A4323. Review.

PMID:
21975154
[PubMed - indexed for MEDLINE]
Free Article
18.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
[PubMed - indexed for MEDLINE]
19.

Lessons from the US rotavirus vaccination program.

Glass RI, Patel M, Parashar U.

JAMA. 2011 Oct 19;306(15):1701-2. doi: 10.1001/jama.2011.1475. No abstract available.

PMID:
22009102
[PubMed - indexed for MEDLINE]
20.

WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005.

Wood D; WHO Informal Consultative Group.

Vaccine. 2005 Dec 1;23(48-49):5478-87. Epub 2005 Aug 2.

PMID:
16129525
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk